CELLESCE
Cellesce Ltd is a biochemical engineering company based in Cardiff in the UK. Cellesce's expertise is in cell expansion which is currently focused on organoids.
CELLESCE
Industry:
Biotechnology Manufacturing
Founded:
2013-01-01
Address:
Malmesbury, Wiltshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cellesce.com
Total Employee:
1+
Status:
Active
Contact:
+44 (0)1225 587 800
Total Funding:
1.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress ReCAPTCHA Contact Form 7 WordPress 6.0 Pound Sterling
Similar Organizations
AQEMIA
Drug discovery - Pharma 3.0
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Investors List
Tangram Partners Limited
Tangram Partners Limited investment in Seed Round - Cellesce
Development Bank of Wales
Development Bank of Wales investment in Venture Round - Cellesce
Newest Events participated
Participated in Angels in MedCity Pitching Event Nov-2016
on 2016-11-10 as exhibitor
Official Site Inspections
http://www.cellesce.com Semrush global rank: 7.05 M Semrush visits lastest month: 619
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 52.216.221.141
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Cellesce"
Cellesce – Growing and scale up of patient derived organoids
Cellesce uses its proprietary bioprocess and bioreactors for the expansion of human-derived normal and cancer PDOs for multiple applications, including drug screening. Learn more …See details»
Cellesce - Crunchbase Company Profile & Funding
Organization. Cellesce . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. 3D organoids for drug discovery assays. ... Cellesce may be growing as it is preparing to leave its …See details»
Cellesce Company Profile 2024: Valuation, Investors, …
Cellesce General Information Description. Provider of biochemical and bioprocess engineering services intended for drug discovery and organ-on-a-chip applications. The company bioprocessing technology, and specializes in the …See details»
Cellesce - VentureRadar
Cellesce’s patented ‘disruptive’ bioprocess, now in its second generation has enabled a significant increase in PDO production compared to manual processes. Furthermore, better process …See details»
Cellesce Ltd: Contact Details and Business Profile
The NAICS codes for Cellesce Ltd are [54, 5417, 541713, 54171, 541]. What is the SIC code for Cellesce Ltd? The SIC codes for Cellesce Ltd are [873, 87]. Top Cellesce Ltd Employees …See details»
Cellesce - Company Profile - Tracxn
Nov 28, 2024 Cellesce - Develops scalable process for expansion of organoids. Acquired by Molecular Devices. Raised funding over 2 rounds from 6 investors. Founded by Marianne Ellis …See details»
Cellesce - Overview, News & Similar companies | ZoomInfo.com
Cellesce provides PDO models to the pharma and biotech industry to drive improved cancer drug discovery, more products to market and better treatments for patients. The company's goal is …See details»
Cellesce Company Profile - Office Locations, Competitors ... - Craft
Cellesce has 5 employees at their 1 location. See insights on Cellesce including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Cellesce’s Competitors, Revenue, Number of Employees, Funding …
Cellesce: Life sciences firm Cellesce exits Cardiff Medicentre for larger labs in the capital. Jan 16, 2023. Global Legal Chronicle. Cellesce: Molecular Devices, LLC's Acquisition of Cellesce Ltd. …See details»
Cellesce | Cardiff, United Kingdom Startup - Gust
Cellesce is a biotechnology company that has developed a new (patent pending) bioprocessing technology for the growing and expansion of organoids. Big pharma, drug discovery …See details»
Cellesce - Contacts, Employees, Board Members, Advisors & Alumni
3D organoids for drug discovery assays.See details»
Cellesce Company Profile | Management and Employees List
Find contact information for Cellesce. Learn about their Business Services market share, competitors, and Cellesce's email format.See details»
Molecular Devices adds proprietary patient-derived organoid …
SAN JOSE, Calif., and CARDIFF, Wales, Dec. 6, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, today announced the acquisition of …See details»
Cellesce scales organoid production for drug discovery using ...
Mar 26, 2019 Cellesce last week announced a license agreement for the scale-up of breast organoids with Hubrecht Organoid Technology (HUB), a not-for-profit organization with a …See details»
Improving Drug Development: Molecular Devices and Cellesce …
Cellesce’s large-scale manufacturing employs proprietary bioreactor and bioprocess technology, allowing large-volume, quality-controlled production of PDOs. “Being able to have and provide …See details»
Organoids - Cellesce
The Cellesce organoid expansion process - efficient, reproducible, scalable Cellesce has invented and patented a unique bioprocess for the expansion of human-derived, normal and cancer …See details»
Cellesce scales organoid production for drug discovery using ...
Mar 26, 2019 Cellesce last week announced a license agreement for the scale-up of breast organoids with Hubrecht Organoid Technology (HUB), a not-for-pro t organization with a …See details»
Cellesce | Sifted: AI-Powered Company Profiles & Insights
Explore company profiles in an instant with Sifted. Dive deep into our AI-generated startup descriptions and competitor analysis.See details»
Organoid innovation offers potential for cancer research - Cellesce
Labs,” says Mark Treherne, Cellesce chief executive. “We have built a scalable process that can be used in applications requiring large numbers of organoids.” Cellesce started with colorectal …See details»
Organization for Security and Co-operation in Europe (OSCE) …
4 days ago The Cold War-era agreement was a result of the détente period, ushering in a reduction in tensions between the United States and the Soviet Union. In 2025, the …See details»